Marina E. Wolf & Anissa Abi-DarghamÂÂ
doi : 10.1038/s41386-022-01458-3
Volume 48 Issue 1, January 2023
Travis E. Brown & Barbara A. SorgÂÂ
doi : 10.1038/s41386-022-01337-x
Overindulgence, excessive consumption, and a pattern of compulsive use of natural rewards, such as certain foods or drugs of abuse, may result in the development of obesity or substance use disorder, respectively.
Anna Kruyer, Peter W. Kalivas & Michael D. ScofieldÂÂ
doi : 10.1038/s41386-022-01338-w
Over the last 15 years, the field of neuroscience has evolved toward recognizing the critical role of astroglia in shaping neuronal synaptic activity and along with the pre- and postsynapse is now considered an equal partner in tripartite synaptic transmission and plasticity.
Andrew Scheyer, Farhana Yasmin, Saptarnab Naskar & Sachin PatelÂÂ
doi : 10.1038/s41386-022-01438-7
Endocannabinoids (eCBs) are lipid neuromodulators that suppress neurotransmitter release, reduce postsynaptic excitability, activate astrocyte signaling, and control cellular respiration.
Ege T. Kavalali & Lisa M. MonteggiaÂÂ
doi : 10.1038/s41386-022-01411-4
Neuronal and synaptic plasticity are widely used terms in the field of psychiatry. However, cellular neurophysiologists have identified two broad classes of plasticity.
Rong Guo, Dylan Thomas Vaughan, Ana Lourdes Almeida Rojo & Yanhua H. HuangÂÂ
doi : 10.1038/s41386-022-01356-8
Our modern society suffers from both pervasive sleep loss and substance abuse�what may be the indications for sleep on substance use disorders (SUDs), and could sleep contribute to the individual variations in SUDs? Decades of research in sleep as well as in motivated behaviors have laid the foundation for us to begin to answer these questions.
Jessica J. Walsh, Daniel J. Christoffel & Robert C. MalenkaÂÂ
doi : 10.1038/s41386-022-01348-8
Positive, prosocial interactions are essential for survival, development, and well-being. These intricate and complex behaviors are mediated by an amalgamation of neural circuit mechanisms working in concert.
Scott M. ThompsonÂÂ
doi : 10.1038/s41386-022-01422-1
What changes in brain function cause the debilitating symptoms of depression? Can we use the answers to this question to invent more effective, faster acting antidepressant drug therapies? This review provides an overview and update of the converging human and preclinical evidence supporting the hypothesis that changes in the function of excitatory synapses impair the function of the circuits they are embedded in to give rise to the pathological changes in mood, hedonic state, and thought processes that characterize depression.
Abigail E. Calder & Gregor HaslerÂÂ
doi : 10.1038/s41386-022-01389-z
Classic psychedelics, such as LSD, psilocybin, and the DMT-containing beverage ayahuasca, show some potential to treat depression, anxiety, and addiction.
Lawrence G. Appelbaum, Mohammad Ali Shenasa, Louise Stolz & Zafiris DaskalakisÂÂ
doi : 10.1038/s41386-022-01370-w
Activity-dependent synaptic plasticity is a ubiquitous property of the nervous system that allows neurons to communicate and change their connections as a function of past experiences.
Daniel N. Scott & Michael J. FrankÂÂ
doi : 10.1038/s41386-022-01374-6
Synaptic plasticity configures interactions between neurons and is therefore likely to be a primary driver of behavioral learning and development.
Gitte M. KnudsenÂÂ
doi : 10.1038/s41386-022-01361-x
The serotonergic classical psychedelics include compounds that primarily activate the brain’s serotonin 2 A receptor (5-HT2AR), such as LSD, psilocybin, and DMT (ayahuasca).
Oliver D. Howes, Connor Cummings, George E. Chapman & Ekaterina ShatalinaÂÂ
doi : 10.1038/s41386-022-01426-x
Over the last five decades, a large body of evidence has accrued for structural and metabolic brain alterations in schizophrenia.
Sophia Vinogradov, Matthew V. Chafee, Erik Lee & Hirofumi MorishitaÂÂ
doi : 10.1038/s41386-022-01451-w
Emerging research on neuroplasticity processes in psychosis spectrum illnesses�from the synaptic to the macrocircuit levels�fill key gaps in our models of pathophysiology and open up important treatment considerations.
Sophie E. Holmes, Chadi Abdallah & Irina EsterlisÂÂ
doi : 10.1038/s41386-022-01368-4
Major depressive disorder is a prevalent and heterogeneous disorder with treatment resistance in at least 50% of individuals.
Ali Jannati, Lindsay M. Oberman, Alexander Rotenberg & Alvaro Pascual-LeoneÂÂ
doi : 10.1038/s41386-022-01453-8
Transcranial magnetic stimulation (TMS) is a non-invasive technique for focal brain stimulation based on electromagnetic induction where a fluctuating magnetic field induces a small intracranial electric current in the brain.
Joseph A. Deluisi & Desmond J. OathesÂÂ
Marcus W. Meinhardt & Wolfgang H. SommerÂÂ
Thomas D. Prevot & Etienne SibilleÂÂ
Katherine M. Nautiyal & David B. YadenÂÂ
Holly K. Hamilton & Daniel H. MathalonÂÂ
Valerie J. Sydnor & Theodore D. SatterthwaiteÂÂ
Emir Malovic & Subhash C. PandeyÂÂ
Joshua S. Siegel & Ginger E. NicolÂÂ
Negar Fani & Sahib S. KhalsaÂÂ
Utsav Gyawali & Morgan H. JamesÂÂ
Robert J. Fenster & Junghyup SuhÂÂ
Carrie R. Ferrario & Julie E. FinnellÂÂ
Jennifer S. Stevens & Alyssa R. RoecknerÂÂ
Michael D. Gregory & Karen F. BermanÂÂ
Stephan F. Taylor & Meghan E. MartzÂÂ
David A. Kupferschmidt & Joshua A. GordonÂÂ
Jeremy J. Day & Keri MartinowichÂÂ
Firoza Mamdani & Adolfo SequeiraÂÂ
Camila N. C. Lima & Gabriel R. FriesÂÂ
Catherine Lebel & Xiangyu LongÂÂ
Noah S. Philip & Amanda R. ArulpragasamÂÂ
Nicole A. Crowley & Scott H. MedinaÂÂ
Barbara O. Rothbaum & Jessica L. Maples-KellerÂÂ
Lauren T. Seabrook & Stephanie L. BorglandÂÂ
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟